Allurion Technologies, Inc. Cost of Revenue
Allurion Technologies, Inc. (ALUR) reported Cost of Revenue of $1.72 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-05-15
- Allurion Technologies, Inc. cost of revenue for the quarter ending 2026-03-31 was $1.72M, a 21.07% increase year-over-year.
- Allurion Technologies, Inc. cost of revenue for the quarter ending 2025-12-31 was $2.00M, a 34.43% decline year-over-year.
- Allurion Technologies, Inc. cost of revenue for the quarter ending 2025-09-30 was $1.35M, a 39.98% decline year-over-year.
- Allurion Technologies, Inc. cost of revenue for the quarter ending 2025-06-30 was $882.00K, a 68.19% decline year-over-year.
- Allurion Technologies, Inc. cost of revenue for fiscal 2025 was $5.66M, a 46.65% decline from fiscal 2024.
- Allurion Technologies, Inc. cost of revenue for fiscal 2024 was $10.61M, a 11.39% decline from fiscal 2023.
- Allurion Technologies, Inc. cost of revenue for fiscal 2023 was $11.97M, a 11.23% decline from fiscal 2022.
- Allurion Technologies, Inc. cost of revenue for fiscal 2022 was $13.48M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.72M 10-Q · filed 2026-05-15 | $3.72M derived: sum of 2 quarters · filed 2026-05-15 | $5.08M derived: sum of 3 quarters · filed 2026-05-15 | $5.96M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.36M derived: sum of 2 quarters · filed 2026-03-30 | $4.24M derived: sum of 3 quarters · filed 2026-03-30 | $5.66M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.35M 10-Q · filed 2025-11-17 | $2.24M derived: sum of 2 quarters · filed 2025-11-17 | $3.65M 10-Q · filed 2025-11-17 | $6.71M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $882.00K 10-Q · filed 2025-08-19 | $2.30M 10-Q · filed 2025-08-19 | $5.36M derived: sum of 3 quarters · filed 2026-05-15 | $7.62M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $1.42M 10-Q · filed 2026-05-15 | $4.48M derived: sum of 2 quarters · filed 2026-05-15 | $6.73M derived: sum of 3 quarters · filed 2026-05-15 | $9.51M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.31M derived: sum of 2 quarters · filed 2026-03-30 | $8.09M derived: sum of 3 quarters · filed 2026-03-30 | $10.61M 10-K · filed 2026-03-30 |
| 2024-09-30 | $2.26M 10-Q · filed 2025-11-17 | $5.03M derived: sum of 2 quarters · filed 2025-11-17 | $7.55M 10-Q · filed 2025-11-17 | $9.35M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $2.77M 10-Q/A · filed 2025-08-28 | $5.29M 10-Q/A · filed 2025-08-28 | $7.10M derived: sum of 3 quarters · filed 2025-08-28 | $11.33M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $2.52M 10-Q/A · filed 2025-08-28 | $4.33M derived: sum of 2 quarters · filed 2025-08-28 | $8.56M derived: sum of 3 quarters · filed 2025-08-28 | $11.55M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $1.80M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $6.04M derived: sum of 2 quarters · filed 2025-08-28 | $9.03M derived: sum of 3 quarters · filed 2025-08-28 | $11.97M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $4.23M 10-Q/A · filed 2025-08-28 | $7.22M derived: sum of 2 quarters · filed 2025-08-28 | $10.16M 10-Q/A · filed 2025-08-28 | $14.10M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $2.99M 10-Q/A · filed 2025-08-28 | $5.93M 10-Q/A · filed 2025-08-28 | $9.87M derived: sum of 3 quarters · filed 2025-08-28 | $13.35M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $2.94M 10-Q/A · filed 2025-08-28 | $6.88M derived: sum of 2 quarters · filed 2025-08-28 | $10.35M derived: sum of 3 quarters · filed 2025-08-28 | $13.85M derived: sum of 4 quarters · filed 2025-08-28 |
| 2022-12-31 | $3.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $7.41M derived: sum of 2 quarters · filed 2025-08-28 | $10.91M derived: sum of 3 quarters · filed 2025-08-28 | $13.48M 10-K/A · filed 2025-08-28 |
| 2022-09-30 | $3.47M 10-Q · filed 2023-11-14 | $6.97M derived: sum of 2 quarters · filed 2023-11-14 | $9.54M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $3.50M 10-Q · filed 2023-10-20 | $6.07M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |